Showing 9091-9100 of 21416 results for "".
Perioperative Immunotherapy in LA-HNSCC: From Evidence to Clinical Practice
https://reachmd.com/programs/cme/perioperative-immunotherapy-in-la-hnscc-from-evidence-to-clinical-practice/56618/Experts explore emerging evidence and multidisciplinary integration of perioperative immunotherapy for resectable, locally advanced HNSCC.IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
https://reachmd.com/programs/cme/ibd-masterclass-foundations-of-pathophysiology-and-targeted-therapy/49149/Examine the biological mechanisms underlying IBD, including genetic, microbial, environmental, and immune pathways that inform therapeutic targets.DESTINY-Breast05: Additional Data From the Interim Analysis
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast05-additional-data-from-the-interim-analysis/49126/Check out the interim DESTINY-Breast05 analysis of T-DXd showing improved IDFS and manageable safety vs T-DM1 in high-risk HER2+ BC with residual disease.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://reachmd.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
https://reachmd.com/programs/cme/sticking-points-managing-injection-site-reactions-from-long-acting-injectable-medications-for-hiv-care/60599/Join our experts to improve your injection administration skills for long-acting injectable HIV drugs to minimize ISRs and enhance patient adherence to therapy.Survey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
https://reachmd.com/programs/cme/survey-says-aligning-early-advanced-ibd-therapy-with-patient-priorities/57916/On-demand webcast on the latest advances in managing inflammatory bowel disease (IBD) and expert-informed strategies for providing guideline-concordant care to patients with IBD.Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
https://reachmd.com/programs/cme/simple-diagnostic-steps-that-change-td-outcomes-increase-quality-of-life/54716/Review standardized screening, symptom recognition, and multidisciplinary management strategies to improve diagnosis and care of tardive dyskinesia.EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
https://reachmd.com/clinical-practice/endocrinology/easd-2026-the-importance-of-protecting-lean-muscle-mass-in-managing-patients-with-obesity/84840/Look beyond weight loss to explore why preserving lean muscle mass is becoming an important consideration in obesity management.The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
https://reachmd.com/programs/cme/the-next-frontier-addressing-persistent-cognitive-impairment-in-bipolar-disorder/56740/Explore this expert series and dive into bipolar disorder recurrence, treatment gaps, neurocircuitry, cognition, and investigational muscarinic therapies.Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/hypertrophic-cardiomyopathy-overcoming-practical-barriers-to-treatment-in-the-era-of-myosin-inhibitors/56414/Dive into practical barriers to myosin inhibitor use in HCM and learn strategies to support timely initiation and access for eligible patients.